Study of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke
Clinical trial NCT02430350 · COMPLETED
Trial details
- NCT number
- NCT02430350
- Sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2016-12-01
- Enrollment
- 1200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.